Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jazz Pharmaceuticals
Bayer
Actuate Therapeutics Inc.
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
Psyence Australia Pty Ltd
Daiichi Sankyo
HealthPartners Institute
Mayo Clinic
Incyte Corporation
Merck Sharp & Dohme LLC
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Tempus AI
Institut Bergonié
Elevation Oncology
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Zhejiang Provincial People's Hospital
Exelixis
Universitair Ziekenhuis Brussel
pharmaand GmbH
Hoffmann-La Roche
Main Line Health
MetiMedi Pharmaceuticals
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Alabama at Birmingham
Georgetown University
National Institutes of Health Clinical Center (CC)
Pfizer